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Abstract. Healthcare systems in western countries are continuously working to
achieve efficient resource allocation and to improve access to quality medical
care. The implementation of standardised care processes promises better
integration and coordination of care across several healthcare providers. In this
context, an increasing use of the term patient pathway is recognised within
official documents provided by health authorities and within scientific
publications in recent years. However, a common understanding, distinguishing
the term from other pathway approaches such as care- or clinical pathways, is
missing. By means of a scoping review we analysed 132 publications in order to
clarify key concepts and the understanding of patient pathways. Six common
themes in the literature were identified and results show that individualisation
and care continuity are essential descriptive characteristics. Using this
motivation, we discuss the main implications for research and practice by the
example of comprehensive cancer care in the European Union.
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1

Introduction

Health care faces a broad spectrum of transition processes that necessitate integrated
care delivery. In this context, demographic change, skilled worker shortage and an
increasing number of patients with multimorbidity and chronic diseases are among the
main drivers [1, 2]. For the latter, cancer is one of the most common and costly diseases
in western countries [3, 4]. In order to coordinate cancer care on the national level and
to increase access to quality cancer care, the implementation of Comprehensive Cancer
Care Networks (CCCNs) is recommended by the European guide on quality
improvement in comprehensive cancer control [5]. Such networks integrate different
institutions and institutional units representing all relevant episodes for a patient’s
cancer care, i. e. research, prevention, diagnosis, treatment, follow-up, rehabilitation
and end-of-life care [5]. One of the CCCNs’ tasks is the provision of practical support
tools. In this context, comprehensive, integrated patient pathways are recognised as a
valuable approach [5]. Whereas the term patient pathway is often used with regard to
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optimising cancer care processes and aligning information and communication flows,
a common terminological basis is still missing. This has negative impact on the
harmonisation of such big scale activities, in this case on EU level, and on the
communication of their maturity in general. Hence, to further advance the utilisation of
patient pathways in cancer care and beyond, clarification of the concept is necessary. It
is still unclear whether patient pathways are any different from already well-established
pathway approaches such as care pathways or clinical pathways. According to the
definition used by the European Pathway Association, a “care pathway is a complex
intervention for the mutual decision making and organisation of care processes for a
well-defined group of patients during a well-defined period“ [6]. Clinical pathways
particularly focus on the care provision within a single institution, e. g. a hospital [7].
The article aims to examine the literature body available on patient pathways. On
this basis, key concepts of patient pathways shall be clarified and implications for future
research and practice shall be discussed. Therefore, three research questions are to be
answered: (RQ1) How has the literature on patient pathways developed over the years
and which themes are addressed in the literature? (RQ2) What are characteristics of
patient pathways including characteristics that differentiate them from other pathway
approaches? (RQ3) What are potential implications for practice and future research?
Accordingly, the article is structured as follows: The scoping review method used to
address the research questions is described in section 2. The results are presented in
section 3 by describing identified themes within the patient pathway literature. Also,
common characteristics of patient pathways are derived within this section. The results
of the review are discussed in the context of current literature and practice in section 4.
This also includes the discussion of implications for research and practice as well as
limitations of our study. A conclusion is given in section 5 by summarising the results
and the contributions of the presented work.

2

Method

2.1

Scoping Review

In order to answer the research questions, a scoping review was conducted. Unlike a
systematic literature review, a scoping review is a review type which is used to map
key concepts underpinning a research area [8, 9]. A common purpose of scoping
reviews is the identification of topics for future research [10]. They are often performed
to determine and represent the body of literature and available evidence on a topic [8].
Since there is yet no comprehensive literature review about patient pathways available,
the conduction of a scoping review is the appropriate choice to answer our research
questions. Also, the research objectives are among those, that Anderson et al. (2008)
state as the key criteria for which a scoping review is reasonable, e. g. clarification of
the conceptual understanding of a topic where definitions are unclear and identification
of research gaps advising on future research [10].
The conduction and reporting of the scoping review follows the guidelines proposed
by Peters et al. [9]. The process of developing a review protocol as well as the literature
search and selection process are not different from a systematic literature review, except
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that there is no formal assessment of the methodological quality of the included
literature [8, 9]. The developed review protocol included the definition of the search
strategy, search terms, databases, screening approach, and the inclusion criteria.
In order to clarify the characteristics of the review, we draw on the established
taxonomy for literature reviews described by Cooper [11] and define the focus, goal,
perspective, coverage, organisation and audience as intended with the scoping review
on patient pathways. The focus areas are outcomes, theories and applications. With
respect to the research objective of this article, the goal of the review is twofold, i. e. it
aims at the identification of central issues (see RQ1 and RQ2) as well as at the
integration of existing literature (see RQ3). We take a neutral perspective in the
presentation of the results and cover literature exhaustively with selected citations due
to space limitations. The review is organised conceptually. The intended audiences are
both scholars and practitioners in the fields of information systems and health care.
2.2

Search Strategy

Records identified through database searching Records identified through grey literature searching
n = 334
n = 59

Records screened
n = 244

Full-texts assessed for eligibility
n = 168

Included

Screening

Records after duplicates removed
n = 244

Eligibility

Identification

The search strategy comprised a scientific database search and a google search in order
to include both scientific articles and grey literature (e. g. government, business or
institution reports regarding patient pathways) [12, 13]. The searches were carried out
in April and May 2018. The search and review process is depicted in Figure 1.
During the screening phase, the exclusion criteria were non-scientific publication
types (e. g. letters to the editors), the unavailability of an English abstract (reasonable
for the results of the database search), or an extraneous topic (e. g. disease specific
research aims that did not have patient pathways as a central topic). The high number
of unavailable database records mostly results from unavailable poster abstracts. In
such cases, the authors were contacted and asked to share their publication.

Records excluded at title and abstract review
n = 76
Exclusion reasons:
- language: 3
- not available: 45
- record type: 3
- extraneous topic: 25
Records excluded at full-text review
n = 36
Exclusion reasons:
- language: 2
- extraneous topic: 34

Records included
n = 132

Figure 1. Scoping review process (representation mode based on [14])
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During the full-text assessment, we did not restrict the analysis to full papers but also
included abstracts, poster abstracts and posters, since one aim of the scoping review is
the analysis of the currently available literature body on patient pathways. Included
full-texts were in English or German, the latter occurring twice.
2.3

Database Search

We searched for "patient pathway" OR "patient pathways" in the titles of articles in
PubMed, EbscoHost Academic Search Complete, Web of Science, and ScienceDirect.
The decision to exclusively search for the term patient pathway is based on initial search
term tests. These tests included potential synonyms such as clinical-, treatment-, care-,
or integrated pathways and tested combinations with terms related to “definition” or
“development”. The searches resulted in a large amount of irrelevant articles and since
the focus of the scoping review is the examination of the term patient pathway, we
decided to exclusively search for this term.
The results were screened based on titles and abstracts by four reviewers. This
procedure meets the requirement for at least two reviewers necessary for a scoping
review [9]. In order to create a common understanding for the screening process a pretest was conducted. Each reviewer analysed the first 15 included records regarding the
context in which the term patient pathway was used. In a consensus meeting, the
findings were discussed and the authors decided on a preliminary classification of
research themes in the literature on patient pathways. This classification was assessed
and refined in a second pre-test by applying it to the first 25 records of the included
records and another consensus meeting. Based on this revised classification, the authors
mapped all included records. During this, minor iterative refinements of the
classification took place, leading to its final version as described in section 3.1.
2.4

Search for Grey Literature

We searched google exclusively for the singular and plural of the term patient pathway,
for the same reasons as described for the database search. The first six results pages
(the first 59 results, excluding hits to language translation pages) were screened by the
authors. After that, there were scarcely any more relevant hits, which justifies ending
the search at this point. The literature classification developed during the pre-test with
the database search results was also applied to the included grey literature.

3

Results

3.1

Themes in the Patient Pathway Literature

As a first, theme-independent result, it can be stated that the interest in the examination
of patient pathways in research and practice has increased over the years. This is shown
by the increase in publications per year as depicted in Figure 2.
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Figure 2. Number of publications per year (n = 132)

The literature can be roughly divided into publications examining patient pathways
in general (n = 39) and publications addressing patient pathways for certain diseases
(n = 93). For the latter, a major focus is on patient pathways in cancer care. As shown
in Figure 3 (a), patient pathways for tuberculosis, heart diseases or alcoholism/drug
addiction were examined much less frequently. The rest of the disease-specific
literature was highly diverse. Thus, all diseases that were addressed only once or twice
in the analysed patient pathway literature were summarised as others.
As described in section 2.3, during the analysis of the titles, abstracts and full-texts
of the searched literature, a classification of six common research themes was
developed and iteratively refined during the process. The identified themes regarding
patient pathways are: definition and conceptualisation, development and
implementation, analysis of patient pathways, responsibilities and roles, tool- and ITsupport, and simulation. The frequency distribution of the themes is depicted in Figure
3 (b). Each theme is described in detail in the following. Themes in the patient pathway literature
Focus of disease-specific patient pathway literature

(number of included records n=132)

(number of disease-specific records n=93)

(a)

(b)

7

6

13
27

29

cancer11
tuberculosis
alcoholism/drug addiction
heart diseases
others
Themes in the patient pathway literature
50

Focus of disease-specific patient pathway literature
(number of disease-specific records n=93)

4

definition and conceptualization
development and implementation
analysis of patient pathways
resoponsibilities and roles
tool- and-IT support
simulation

(number of included records n=132)
3
7

7

29

6
68

13

50

cancer
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11
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27

4

definition and conceptualization
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3
7

Figure 3. Results of the analyses: (a) focus of disease-specific patient pathway literature
(n = 93), (b) themes in the patient pathway literature (n = 132)
68

Definition and Conceptualisation. Currently, there are only few articles (n = 6)
examining characteristics or the notion of patient pathways. However, there is neither
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a comprehensive analysis of the patient pathway approach nor a common definition
available. Instead, the current literature discusses single important issues in relation to
the patient pathway approach. For example, Berntsen and colleagues [15] qualitatively
analysed the goals of care in individual patient pathways and concluded that the
alignment of functional, biological and personal goals in a network of multidisciplinary
care providers is essential to support care continuity. Another issue, addressed by
Salamonsen et al. [16], is the influence of disruptive health and life events on the patient
pathways. Also, they argue that patient pathways are beyond the known concept of
clinical pathways, because they are not solely understood as the standardised,
guideline-based provision of health care for certain patient types but also address
multimorbidity and patient preferences [16]. Further basic characteristics of patient
pathways can be taken from the patient pathway diagram as part of the NHS Data Model
and Dictionary [17]. It describes the attributes and relationships to health care activities
and organisations for the patient pathway class.
Development and Implementation. There are 27 publications that address the issues
of development and implementation of patient pathways. We also included publications
that present concrete patient pathways for certain diseases and health situations in this
theme because they indicate how patient pathways are represented in practice. The
concrete patient pathways analysed for the scoping review were represented as
checklists [18], flowcharts [19] or non-standardised semi-formal process models often
combined with textual descriptions [20, 21]. Standards, clinical practice guidelines or
the results of systematic literature reviews are the starting points for pathway
development and can be complemented by expert knowledge or experiences [22, 23].
Wicke et al. [24] propose a construction process for patient pathways based on a
lifecycle consisting of four phases, i. e. preparation, construction and testing (main
phase), implementation, and maintenance (controlling and revision). In the context of
the latter, the collection of quality, service improvement and redesign tools could be
used to improve certain stages of patient pathways [25]. So far, patient pathway
development is rather addressed in the context of single health care institutions (e. g. a
hospital [24]) than on network level.
The development and implementation are tasks of a multidisciplinary, interorganisational team consisting of all key stakeholders along the patient pathway, e. g.
involving hospital and community staff [23, 24, 26]. The development process should
include consensus team meetings in order to reach agreement between all partners [27,
28]. A prominent example for nationally implemented patient pathways are the Danish
Cancer Patient Pathways that were developed with a consensus seeking model ensuring
the involvement and cooperation between bureaucrats, health professionals and
politicians [29]. Besides the involvement of professional and administrative staff in the
development process, the patient’s perspective is highlighted as well. Focus group
discussions are one way to identify patients’ preferences and to integrate their input in
the pathway development and maintenance phases [30].
Analysis of Patient Pathways. The analysis of patient pathways was subject to more
than half of the publications analysed (n = 68). This theme can be further differentiated
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into four sub-topics, which are (I) patient pathway analysis (n = 16), (II) the analysis of
patient pathway usage (n = 27), (III) the analysis of patient pathway effects (n = 23),
and (IV) the examination of data sources to be used for analysis purposes (n = 2).
Patient pathway analysis (I) is an established phrase being used to describe the
alignment between the care seeking patterns of patients with a certain disease and the
availability of corresponding health care services [31, 32]. In this understanding, the
patient pathway is not a predefined, standardised process but the actual, unplanned
journey of a patient seeking health care services to address her/his health conditions.
Based on this understanding, articles examining the pathways of patients before and
after hospitalisation [33] or how patients decide where to seek care and what factors
influence this decision [34] were also included in this sub-topic. In contrast, the analysis
of the practical usage of patient pathways (II) is based upon predefined, standardised
pathways. This sub-topic includes the analysis of patient characteristics for a certain
patient pathway [35, 36], pathway compliance analyses [37], and process analyses (e. g.
sources of delay [38, 39] or utilisation of certain activities in a pathway [40]). The
analysis of patient pathway effects (III) comprises outcome studies, i.e. the analysis of
the results after patient pathway implementation. Here, patient-related outcomes, such
as survival and mortality, complications, quality of life and treatment-related sideeffects [41, 42], and organisation-related outcomes, such as waiting times, length of
hospital stay or timeliness of care [43, 44], are the focus. Another, rather minor subtopic is the examination of data sources that can be used for analysis purposes (IV). In
this context, the need for data linkage of electronic health records with clinical data
registries as well as across regional borders is highlighted [45, 46]. This would increase
the understanding of the complete patient pathway covering multiple involved care
providers and also support national research.
Responsibilities and Roles. The responsibilities and roles of different stakeholder
groups are discussed in 11 of the analysed articles. The role of nurses turned out be
particularly important for patient navigation and early patient pathway optimisation,
i.e. coordinating interventions, streamlining and planning the pathway, tailoring
interventions to individual patient’s needs and preferences [47–49]. The literature
examines the relevance of nurses for patient management and for the provision of
seamless care in both the acute care (clinical nurse specialists [47, 48]) and non-acute
care setting (community nurses [49]). Other roles and their impact on patient pathways
addressed in the literature are emergency care practitioners [50] and community
pharmacists [51]. The import role of patients themselves is reflected with the patientcentred approach called user-led health care. It describes the systematic involvement of
patients in the planning and execution of their individual treatment and care process
and aligns patients’ responsibilities with their preferences [52].
Tool- and IT-Support. Improving the utilisation and the streamlining of patient
pathways by tools and information technology is a central issue for 13 of the analysed
literature records. Here, patient education and patient empowerment by the online
provision of information materials are typical applications. For example, there are
internet-based, interactive patient pathways used as education tools for breast cancer
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patients [53] or to explain a forthcoming surgical journey [54], and interactive,
individualised online patient pathways with detailed, personalised timelines to keep
patients informed and involved [55]. Another topic in relation to tool- and IT-support
is the use of telemedicine in order to streamline a patient pathway, e. g. with early teleassessment of stroke patients [56]. Furthermore, there are triage tools to assess and
allocate patients to the appropriate pathway [57] and technical solutions for tracking
patient pathways [58].
Simulation. The literature addressing simulation of patient pathways (n = 7) applies it
for example to predict their outcomes. Simulation models are used to produce
quantified output of patients with a certain diagnosis [59] or to simulate scenarios at the
population level in order to support intervention planning of public health care [60].
Furthermore, simulation is used for teaching and training purposes, e. g. by fully
simulating a hospital across the entire patient pathway in order to train expert health
care providers [61] or by simulating the surgical patient pathway for undergraduate
students to supplement classroom medicine and clinical practice [62].
3.2

Characteristics of patient pathways

The scoping review results show that currently a common definition of patient
pathways is not available. However, characteristics of this approach can be identified
from the included literature by analysing their understanding of patient pathways. It
was found that there are related pathway terms also used as synonyms for patient
pathways. Mainly, these are care pathways [47, 49, 63–65], treatment pathways [47,
66, 67], and patient journeys [45, 68, 69]. However, the usage of these terms was not
reasoned in the articles. The full-texts of the included literature were screened for
statements describing characteristics of patient pathways, such as:
“[…] ’patient pathways’ from a patient perspective, understood as incorporated
into socioculturally constructed life courses. […] Not only ‘health events’, but also ‘life
events’ are included in our understanding of patient pathways.” [16]
“Based on treatment guidelines, patient pathways display an optimal sequence of
staff actions in the preoperative, operative, and postoperative in- and outpatient
treatment.” [24]
“Patient pathways are tools that assist in providing general guidelines of care for
dealing with individuals and groups of patients suffering from a wide variety of
diseases.” [70]
Based on the analysis of such statements and the identified themes in the literature,
descriptive characteristics of patient pathways can be summarised as follows. Patient
pathways are:
• stating and aligning functional, biological, and patient-related goals of care [15, 16],
• focusing on patient group and individual patient planning and -management for
complex long-term conditions [16, 70–72],
• describing and sequencing key components of care to guide care provision and the
patient journey [18–21, 23, 24],
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• comprising the whole route a patient takes including inpatient and outpatient settings
and thus, are typically inter-organisational pathways [45, 68, 71, 73] but individual
stakeholders can focus on single episodes (e. g. surgery or hospital stay) [24]
• developed, implemented and used by a multidisciplinary care team consisting of
professional and informal caregivers and involving the patient [23, 24, 26, 30, 52],
• evidence-based (medical guidelines, standards) and experts’ experiences [22, 23],
• used for patient information, documentation, monitoring and evaluation purposes
(e. g. assessment of quality and efficiency of care delivery or patient-related outcome
measures) [37–44, 53, 55, 74].

4

Discussion

As the analysis revealed, more than half of the reviewed publications are related to
oncological diseases. This emphasises the initial statement that patient pathways are
recognised as a valuable approach in cancer care in order to create seamless care, inform
the patient, plan the care process, and implement medical guidelines [5]. The results of
the scoping review also show that the majority of publications addresses the analysis of
various aspects related to patient pathways such as the effects of their application or
their usage (see Figure 3 (b)). Still, the broad use of the term indicates some ambiguity
in its understanding. Surprisingly, there are a lot of papers analysing effects of patient
pathways but without referring to a common definition of this concept.
Although some papers discuss the use of patient pathway in an intra-organisational
context and other focus on the inter-organisational setting, the proposed characteristics
cover both aspects because patient pathways within a single institution are also
embedded in the inter-organisational route of a patient. Interfaces and the relation to
the overall process have to be described accordingly. Furthermore, ambiguity exists
regarding the time perspective of patient pathways. Some authors focus more on the
general journey of patients through the health care delivery system, analysed
retrospectively for example by means of patient pathway analysis. Others rather focus
on prospectively defined pathways for a patient (group) to guide the provision of care.
The latter highlights the planning character of a pathway, which is also the aim of
related pathway approaches such as clinical pathways and care pathways.
In the context of existing literature on other pathway approaches, patient pathways
comprise the core concept of care pathways, that are already well established in the
field of medical process management nowadays [75, 76]. However, patient pathways
have a stronger focus on the individual patient. This is particularly apparent in form of
aligning the goals of care to a patient’s needs and preferences and, accordingly,
tailoring the pathway to the individual. The concept of patient pathways emphasises the
care process from the perspective of the patient and also includes mechanisms of
empowerment and engagement. Based on the identified characteristics, patient
pathways are also not equivalent to clinical pathways [7] because these typically do not
cover the whole care chain across in- and outpatient settings.
The current state of literature provides several action points for future research. A
consensus regarding the patient pathway understanding should be developed, e. g. by
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an expert panel discussing and rating the identified characteristics. From a practical
perspective, a stronger methodological support for developing and implementing
patient pathways is desirable. This could be achieved by providing a tool for the
preparation of patient pathways, their adaption to patient-individual characteristics and
to local specifics of the application environment. Latest research, e. g. on adaptive and
personalised pathways [77] or on multi-perspective pathway modelling languages [78],
can be exploited for this purpose. The mechanisms of reference modelling [79] might
provide appropriate means to combine generic templates with intended governance for
health process design. Taking up the example of comprehensive cancer care, a method
for patient pathway development could allow CCCNs to prepare common templates of
patient pathways for specific tumour entities. These could for example specify the main
goals, phases and milestones of care for a specific patient type as well as roles and tasks
within the care network. Such a template, functioning as a reference model, could then
be adapted to regional conditions and patient individualities based on adaption
guidelines provided along with the method. In order to increase usability, the
specification of user requirements is essential, since the users have an applicationoriented background being e. g. physicians, nurses or a cancer patient. In perspective,
this approach could increase comparability and set process-oriented quality standards
for cancer care in CCCNs. This could contribute to developing more process-oriented
measures for quality and performance assessment. Thereby, insights for continuous
patient pathway improvement could be gained.
Critically reflecting on the methodological approach of the presented paper, the
scoping review could be broadened by expanding the database search to titles and
abstracts and by adding forward and backward searches. The mapping of the literature
could be enriched by a multi-disciplinary review team [10] that also involves scholars
from the health care domain. Due to the nature of the scoping review it does not include
a process of quality assessment of the literature and thus, has some limitations [8]. For
this reason, recommendations for practice are preliminary and the understanding of
patient pathways could be further examined by a systematic literature review. The
conducted scoping review determined the high value and scope of such.

5

Conclusion

The article aimed at examining the current literature body available on patient pathways
in order to clarify key characteristics of this approach and to discuss implications for
research and practice. A systematic scoping review was conducted. It included a
database and a grey literature search. An increase in the discussion of the concept in the
literature was confirmed. There were six common themes identified in the current
literature on patient pathways. These are definition and conceptualisation, development
and implementation, analysis of patient pathways, responsibilities and roles, tool- and
IT-support, and simulation. The majority of publications addresses analytical topics,
such as the analysis of patient pathway usage or effects but a common definition is
currently not available. However, there are typical characteristics of patient pathways
that were summarised based on the reviewed literature. Patient pathways differ from
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other pathway approaches as they rather aim at planning care for multimorbid patients
with complex health conditions. They focus on the inter-organisational setting and
patients’ needs and preferences. We also discussed potential implications for practice
and research. Particularly, the methodological and technological support for developing
and implementing patient pathways should be improved.
The presented work contributes to the knowledge base by consolidating the
understanding of patient pathways and by summarising typical characteristics. As we
pointed out, the patient pathway approach builds upon the core concept of care
pathways. Since there are concerns regarding the feasibility of care pathways for
complex health conditions that require integrated care, we see the opportunity that
patient pathways drive a transition to a broader utilisation of pathways for chronic and
complex health conditions such as cancer. In summary, our work informs the debate on
patient pathways and is a starting point for future research and practical applications.
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